Protara Therapeutics (TARA) Total Debt (2020)

Protara Therapeutics' (TARA) quarterly Total Debt came in at $370793.0 in Q3 2020, down 60.0% on a QoQ basis from $926983.0 in Q2 2020.

Protara Therapeutics (TARA) Total Debt (2020) Analysis & Trends

Protara Therapeutics (TARA) has 1 years of Total Debt data on file, last reported at $370793.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	110.96 Mn
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	959.06 Mn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	1.99 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Protara Therapeutics	233.61 Mn	233.61 Mn	-	-

Download Data